Literature DB >> 32265297

Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases.

Dakshinamurthy Sivakumar1, Vikash Kumar1,2, Michael Naumann2, Matthias Stein3.   

Abstract

The ovarian tumor domain (OTU) deubiquitinylating cysteine proteases OTUB1 and OTUB2 (OTU ubiquitin aldehyde binding 1 and 2) are representative members of the OTU subfamily of deubiquitinylases. Deubiquitinylation critically regulates a multitude of important cellular processes, such as apoptosis, cell signaling, and growth. Moreover, elevated OTUB expression has been observed in various cancers, including glioma, endometrial cancer, ovarian cancer, and breast cancer. Here, using molecular dynamics simulation approaches, we found that both OTUB1 and OTUB2 display a catalytic triad characteristic of proteases but differ in their configuration and protonation states. The OTUB1 protein had a prearranged catalytic site, with strong electrostatic interactions between the active-site residues His265 and Asp267 In OTUB2, however, the arrangement of the catalytic triad was different. In the absence of ubiquitin, the neutral states of the catalytic-site residues in OTUB2 were more stable, resulting in larger distances between these residues. Only upon ubiquitin binding did the catalytic triad in OTUB2 rearrange and bring the active site into a catalytically feasible state. An analysis of water access channels revealed only a few diffusion trajectories for the catalytically active form of OTUB1, whereas in OTUB2 the catalytic site was solvent-accessible, and a larger number of water molecules reached and left the binding pocket. Interestingly, in OTUB2, the catalytic residues His224 and Asn226 formed a stable hydrogen bond. We propose that the observed differences in activation kinetics, protonation states, water channels, and active-site accessibility between OTUB1 and OTUB2 may be relevant for the selective design of OTU inhibitors.
© 2020 Sivakumar et al.

Entities:  

Keywords:  OTU deubiquitinase ubiquitin aldehyde binding; allosteric regulation; catalytic triad; computational analysis; cysteine protease; deubiquitylation (deubiquitination); molecular dynamics; ovarian cancer; ubiquitin thioesterase (OTUB1); ubiquitin-dependent protease

Mesh:

Substances:

Year:  2020        PMID: 32265297      PMCID: PMC7242701          DOI: 10.1074/jbc.RA120.013073

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Otubains: a new family of cysteine proteases in the ubiquitin pathway.

Authors:  Maxim Y Balakirev; Sergey O Tcherniuk; Michel Jaquinod; Jadwiga Chroboczek
Journal:  EMBO Rep       Date:  2003-05       Impact factor: 8.807

Review 2.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

3.  Expansion of access tunnels and active-site cavities influence activity of haloalkane dehalogenases in organic cosolvents.

Authors:  Veronika Stepankova; Morteza Khabiri; Jan Brezovsky; Antonin Pavelka; Jan Sykora; Mariana Amaro; Babak Minofar; Zbynek Prokop; Martin Hof; Rudiger Ettrich; Radka Chaloupkova; Jiri Damborsky
Journal:  Chembiochem       Date:  2013-04-05       Impact factor: 3.164

4.  OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function.

Authors:  Yu-Chi Juang; Marie-Claude Landry; Mario Sanches; Vinayak Vittal; Charles C Y Leung; Derek F Ceccarelli; Abigail-Rachele F Mateo; Jonathan N Pruneda; Daniel Y L Mao; Rachel K Szilard; Stephen Orlicky; Meagan Munro; Peter S Brzovic; Rachel E Klevit; Frank Sicheri; Daniel Durocher
Journal:  Mol Cell       Date:  2012-02-10       Impact factor: 17.970

5.  Selectively Modulating Conformational States of USP7 Catalytic Domain for Activation.

Authors:  Ayşegül Özen; Lionel Rougé; Charlene Bashore; Brian R Hearn; Nicholas J Skelton; Erin C Dueber
Journal:  Structure       Date:  2017-12-14       Impact factor: 5.006

6.  Structural and functional roles of asparagine 175 in the cysteine protease papain.

Authors:  T Vernet; D C Tessier; J Chatellier; C Plouffe; T S Lee; D Y Thomas; A C Storer; R Ménard
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

7.  Evidence for bidentate substrate binding as the basis for the K48 linkage specificity of otubain 1.

Authors:  Tao Wang; Luming Yin; Eric M Cooper; Ming-Yih Lai; Seth Dickey; Cecile M Pickart; David Fushman; Keith D Wilkinson; Robert E Cohen; Cynthia Wolberger
Journal:  J Mol Biol       Date:  2009-01-13       Impact factor: 5.469

8.  OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis.

Authors:  Tycho E T Mevissen; Manuela K Hospenthal; Paul P Geurink; Paul R Elliott; Masato Akutsu; Nadia Arnaudo; Reggy Ekkebus; Yogesh Kulathu; Tobias Wauer; Farid El Oualid; Stefan M V Freund; Huib Ovaa; David Komander
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

9.  The human otubain2-ubiquitin structure provides insights into the cleavage specificity of poly-ubiquitin-linkages.

Authors:  Mikael Altun; Thomas S Walter; Holger B Kramer; Patrick Herr; Alexander Iphöfer; Johan Boström; Yael David; Alia Komsany; Nicola Ternette; Ami Navon; David I Stuart; Jingshan Ren; Benedikt M Kessler
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

10.  Structural basis and specificity of human otubain 1-mediated deubiquitination.

Authors:  Mariola J Edelmann; Alexander Iphöfer; Masato Akutsu; Mikael Altun; Katalin di Gleria; Holger B Kramer; Edda Fiebiger; Sirano Dhe-Paganon; Benedikt M Kessler
Journal:  Biochem J       Date:  2009-03-01       Impact factor: 3.857

View more
  6 in total

1.  OTUB2 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells by PJA1 Deubiquitylation.

Authors:  Gang Hu; Jianwu Yang; Hongwen Zhang; Zhen Huang; Heming Yang
Journal:  Cell Mol Bioeng       Date:  2022-02-01       Impact factor: 3.337

Review 2.  The Emerging Role of OTUB2 in Diseases: From Cell Signaling Pathway to Physiological Function.

Authors:  Jun Li; Na Zhang; Meihua Li; Tao Hong; Wei Meng; Taohui Ouyang
Journal:  Front Cell Dev Biol       Date:  2022-03-02

3.  ERK/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1.

Authors:  Xiaodan Zhong; Tao Wang; Wenjun Zhang; Mengwen Wang; Yang Xie; Lei Dai; Xingwei He; Thati Madhusudhan; Hesong Zeng; Hongjie Wang
Journal:  J Biol Chem       Date:  2022-04-28       Impact factor: 5.486

4.  OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma.

Authors:  Li Liu; Hu Cheng; Min Ji; Liping Su; Ziyang Lu; Xiayun Hu; Yaling Guan; Jinling Xiao; Lijuan Ma; Wei Zhang; Hongwei Pu
Journal:  Biol Proced Online       Date:  2022-07-18       Impact factor: 7.717

5.  Computational Study on Selective PDE9 Inhibitors on PDE9-Mg/Mg, PDE9-Zn/Mg, and PDE9-Zn/Zn Systems.

Authors:  Dakshinamurthy Sivakumar; Sathishkumar Mudedla; Seonghun Jang; Hyunjun Kim; Hyunjin Park; Yonwon Choi; Joongyo Oh; Sangwook Wu
Journal:  Biomolecules       Date:  2021-05-10

6.  Binding of SARS-CoV Covalent Non-Covalent Inhibitors to the SARS-CoV-2 Papain-Like Protease and Ovarian Tumor Domain Deubiquitinases.

Authors:  Dakshinamurthy Sivakumar; Matthias Stein
Journal:  Biomolecules       Date:  2021-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.